Etopophos®, etoposide a topoisomerase inhibitor indicated for the treatment of patients with:
- Refractory Testicular Tumors – Etopophos is indicated, in combination with other chemotherapeutic drugs, for treatment of patients with refractory testicular tumors.
- Small Cell Lung Cancer – Etopophos is indicated, in combination with cisplatin, for first line treatment of patients with small cell lung cancer.